Paris-based TISSIUM raises €50M in Series D round to launch its first tissue reconstruction products

Published on May 23, 2023

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series D round of financing, raising €50 million from new and existing international investors, including Fonds Stratégique des Transitions, managed by ISALT, Merieux Developpement and returning Cathay Health, Credit Mutuel Innovation and Sofinnova Partners. This latest funding round…

This content is for members only. Visit the site and log in/register to read.

The post Paris-based TISSIUM raises €50M in Series D round to launch its first tissue reconstruction products appeared first on EU-Startups.

Continue reading on website
Other news

Paris-based Cybervadis secures €7 million Series A round to secure organizations’ global supply chain

May 23, 2023
CyberVadis, provider of a Third Party Cyber Risk Management platform embedding the most reliable cybersecurity ratings, has raised €7 million in Series-A funding led by Zobito AB. The fresh capital will be used to hire top talent and expand its team to service new clients beyond its traditional markets, as well as to accelerate innovation… This content is for members only. Visit the site and log i

Want to Build a Compelling Workplace That Attracts and Retains Employees? You Need to Provide Them With Value. Here's How.

May 23, 2023
Businesses that emphasize creating value for employees find and keep the best recruits.